Press Releases

Date	Title	Company
20-Dec-2023	Meilleur Technologies Inc. Announces Execution of Manufacturing Agreement with PharmaLogic for Production of the Next-Generation Amyloid PET Imaging Biomarker, NAV4694	Businesswire
20-Dec-2023	Harm Reduction Therapeutics Introduces RiVive™, Over-the-Counter Opioid Overdose Reversal Medication	Businesswire
20-Dec-2023	Global Manual Resuscitator Industry on an Upward Trajectory, Forecasted to Hit US$ 845.3 Million by 2030 at 5.7% CAGR \| FMI	MARKITWIRED
20-Dec-2023	Global Automated Cell Culture Systems Industry Aims for US$ 20.87 Billion by 2030, Backed by FMI’s Projections of 8.4% CAGR	MARKITWIRED
20-Dec-2023	Global Oligonucleotide API Industry Poised for a Remarkable US$ 5.36 Billion Growth, Fueled by a Steady 10.2% CAGR till 2030 \| FMI	MARKITWIRED
20-Dec-2023	Global Injectable Benzodiazepine Industry Set to Achieve US$ 356 Million by 2032 with a Noteworthy 2.7% CAGR \| FMI	MARKITWIRED
20-Dec-2023	Mr. Wilbur L. Ross, Former United States Secretary of Commerce, Joins Board of Coya Therapeutics, Inc.	Businesswire
20-Dec-2023	Simulations Plus Announces First Quarter Fiscal Year 2024 Earnings and Conference Call Date	Businesswire
20-Dec-2023	Liquid Dietary Supplements Market Economic Downturn Analysis: Impact of Recession in 2023	The Wire Times
20-Dec-2023	Savara Added to the NASDAQ Biotechnology Index	Businesswire
20-Dec-2023	Enveric Biosciences to Participate in Biotech Showcase 2024 During “J.P. Morgan Week 2024”	Businesswire
20-Dec-2023	Evolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in Europe	Businesswire
20-Dec-2023	Rallybio Announces Preliminary Phase 1 Multiple Ascending Dose Data for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5	Businesswire
20-Dec-2023	ZCG-Backed Unimed Appoints Søren Andersen as CEO	Businesswire
20-Dec-2023	858 Therapeutics Expands Leadership Team to Support Transition to the Clinic	Businesswire
20-Dec-2023	Companion Animal Diagnostics Market Recent Developments in the Market with Key Players Announcements, , growing at a CAGR of 8.6% from 2022 to 2031	The Wire Times
20-Dec-2023	Global Melanoma Treatment Market Poised to Surpass $12 Billion by 2028, Driven by Advances in Immunotherapy and Targeted Therapies - ResearchAndMarkets.com	Businesswire
20-Dec-2023	Global Guidewires Industry on Track to Attain US$5.9 Billion Valuation by 2030, Fueled by a 6.1% CAGR \| FMI	MARKITWIRED
20-Dec-2023	RadioGel Precision Radionuclide Therapy Receives FDA Breakthrough Device Designation	Vivos Inc.
20-Dec-2023	IAMA Therapeutics Announces Approval of Clinical Trial Application (CTA) by the Italian Medicines Agency (AIFA) to Initiate a Phase 1 Study of IAMA-6 for the Treatment of Autism and Epilepsy	Businesswire